It's anyone's guess what's going to happen here. I sold out off the back of the BI decision based on:
- My assumption is the drug interaction issue is likely to doom the DR trial also
- The cash burn rate of $6m a quarter is unsustainable for a company with a market cap of $40m
- LOXL2 has been trying to find a partner for 2 years - my assumption is increasingly that any potential deal will have limited up front
- the rest of the portfolio is in phase one and has limited value
The best potential outcome would be an acquisition with a sizable premium, but in my view this would only occur if the price falls back to a lower market cap. My view is pessimistic given I got burnt, so take it with a grain of salt.
Realistic views pls, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $53.54M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 250000 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 311426 | 3 |
View Market Depth
| Last trade - 09.42am 30/09/2024 (20 minute delay) ? |
| SNT (ASX) Chart |
Day chart unavailable